Clinical Trial Update: Diversity in Patients With OAB

View source ↗

Summary

A clinical trial update from University Hospital Ghent notes a NOT_YET_RECRUITING study exploring diversity in patients with overactive bladder, including inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Overactive Bladder, Diversity | Status: NOT_YET_RECRUITING